322 related articles for article (PubMed ID: 25656489)
1. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
[TBL] [Abstract][Full Text] [Related]
2. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Jan; 102():425-35. PubMed ID: 25459942
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Electrophoresis; 2015 Feb; 36(4):577-87. PubMed ID: 25393935
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Mol Biosyst; 2015 Sep; 11(9):2429-40. PubMed ID: 26131452
[TBL] [Abstract][Full Text] [Related]
6. Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP/PS1 mouse model using integrated metabolomic approaches.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochimie; 2015 Mar; 110():119-128. PubMed ID: 25597416
[TBL] [Abstract][Full Text] [Related]
7. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
Chang KL; Wong LR; Pee HN; Yang S; Ho PC
Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2014 Sep; 98():321-6. PubMed ID: 24992214
[TBL] [Abstract][Full Text] [Related]
9. Gender differences of peripheral plasma and liver metabolic profiling in APP/PS1 transgenic AD mice.
Wu J; Fu B; Lei H; Tang H; Wang Y
Neuroscience; 2016 Sep; 332():160-9. PubMed ID: 27393253
[TBL] [Abstract][Full Text] [Related]
10. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a
Zhou Q; Zheng H; Chen J; Li C; Du Y; Xia H; Gao H
Metab Brain Dis; 2018 Oct; 33(5):1661-1668. PubMed ID: 29946959
[TBL] [Abstract][Full Text] [Related]
13. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
14. Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry.
González-Domínguez R; Castilla-Quintero R; García-Barrera T; Gómez-Ariza JL
Anal Biochem; 2014 Nov; 465():20-7. PubMed ID: 25064643
[TBL] [Abstract][Full Text] [Related]
15. Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease.
Fabelo N; Martín V; Marín R; Santpere G; Aso E; Ferrer I; Díaz M
J Neuropathol Exp Neurol; 2012 Oct; 71(10):868-81. PubMed ID: 22975585
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.
Durani LW; Hamezah HS; Ibrahim NF; Yanagisawa D; Nasaruddin ML; Mori M; Azizan KA; Damanhuri HA; Makpol S; Wan Ngah WZ; Tooyama I
J Alzheimers Dis; 2018; 64(1):249-267. PubMed ID: 29889072
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
18. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
[TBL] [Abstract][Full Text] [Related]
19. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer's disease.
Xian-hui D; Wei-juan G; Tie-mei S; Hong-lin X; Jiang-tao B; Jing-yi Z; Xi-qing C
J Trace Elem Med Biol; 2015 Apr; 30():118-23. PubMed ID: 25575693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
